Home/Filings/4/0000950170-24-076211
4//SEC Filing

Dreyfus Andrew 4

Accession 0000950170-24-076211

CIK 0001446847other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:05 PM ET

Size

5.1 KB

Accession

0000950170-24-076211

Insider Transaction Report

Form 4
Period: 2024-06-18
Transactions
  • Award

    Class A Common Stock

    2024-06-18+24,311188,230 total
Footnotes (2)
  • [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
  • [F2]Since the date of the reporting person's last ownership report, the individual transferred 5,061 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.

Documents

1 file

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001670893

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:05 PM ET
Size
5.1 KB